SC
BSX icon

Stance Capital’s Boston Scientific BSX Stock Holding History

Stance Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27K Buy
+100
New +$5.43K ﹤0.01% 310
2025
Q4 		– Sell
-21,998
Closed -$2.15M – 156
2025
Q3 		$2.15M Buy
21,998
+18,915
+614% +$1.96M 0.79% 31
2025
Q2 		$331K Sell
3,083
-38,814
-93% -$3.93M 0.12% 153
2025
Q1 		$4.23M Sell
41,897
-5,358
-11% -$540K 3.12% 10
2024
Q4 		$4.22M Buy
+47,255
New +$4.16M 2.61% 13

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stance Capital's BSX Position: Q2 2026 in Review

Stance Capital opened a new position in Boston Scientific (BSX) in Q2 2026: 100 shares worth $4.27K. The stake represents ﹤0.01% of the portfolio and ranks #310 among its holdings. This is a return to the name: Stance Capital previously reported a position in BSX as recently as Q3 2025.

Stance Capital first reported a position in BSX in Q4 2024 and has held it in 5 quarters since. The position peaked at $4.23M in Q1 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Stance Capital held 100 shares of Boston Scientific worth $4.27K as of Q2 2026.
  • Boston Scientific was a new Stance Capital position in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Stance Capital's portfolio in Q2 2026, its #310 holding.
  • Stance Capital first reported a position in Boston Scientific in Q4 2024 and has held it in 5 quarters since.
  • Stance Capital's Boston Scientific position peaked at $4.23M in Q1 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.